Haematological Disease

Patients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Estcourt, L, Stanworth, S, Murphy, M
Aineistotyyppi: Book section
Julkaistu: John Wiley and Sons 2013
_version_ 1826307335106068480
author Estcourt, L
Stanworth, S
Stanworth, S
Murphy, M
Murphy, M
author_facet Estcourt, L
Stanworth, S
Stanworth, S
Murphy, M
Murphy, M
author_sort Estcourt, L
collection OXFORD
description Patients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the management of ABO mismatched stem cell transplants, the investigation and management of patients who become refractory to platelets and the use of irradiated and CMV-safe blood components. This edition first published 2013 © 2001, 2005, 2009, 2013 John Wiley and Sons Ltd.
first_indexed 2024-03-07T07:01:40Z
format Book section
id oxford-uuid:bb8cde37-3c21-4216-afdb-02ffff40ef72
institution University of Oxford
last_indexed 2024-03-07T07:01:40Z
publishDate 2013
publisher John Wiley and Sons
record_format dspace
spelling oxford-uuid:bb8cde37-3c21-4216-afdb-02ffff40ef722022-03-29T17:19:00ZHaematological DiseaseBook sectionhttp://purl.org/coar/resource_type/c_3248uuid:bb8cde37-3c21-4216-afdb-02ffff40ef72Symplectic Elements at OxfordJohn Wiley and Sons2013Estcourt, LStanworth, SStanworth, SMurphy, MMurphy, MPatients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the management of ABO mismatched stem cell transplants, the investigation and management of patients who become refractory to platelets and the use of irradiated and CMV-safe blood components. This edition first published 2013 © 2001, 2005, 2009, 2013 John Wiley and Sons Ltd.
spellingShingle Estcourt, L
Stanworth, S
Stanworth, S
Murphy, M
Murphy, M
Haematological Disease
title Haematological Disease
title_full Haematological Disease
title_fullStr Haematological Disease
title_full_unstemmed Haematological Disease
title_short Haematological Disease
title_sort haematological disease
work_keys_str_mv AT estcourtl haematologicaldisease
AT stanworths haematologicaldisease
AT stanworths haematologicaldisease
AT murphym haematologicaldisease
AT murphym haematologicaldisease